Results 171 to 180 of about 15,512,775 (299)
A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design. [PDF]
Belin L, Broët P, De Rycke Y.
europepmc +1 more source
Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic +15 more
wiley +1 more source
A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up. [PDF]
Belin L, De Rycke Y, Broët P.
europepmc +1 more source
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach +9 more
wiley +1 more source
Two-stage design for phase II oncology trials with relaxed futility stopping. [PDF]
Ivanova A, Deal AM.
europepmc +1 more source
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang +9 more
wiley +1 more source
The two-stage stroyboarding experience design method
Design practitioners and researchers acknowledge the benefits of using graphical representations and storyboards to communicate and elaborate designs.
Michailidou, Ioanna; Haid, Charlotte; Gebauer, Cornelia; Lindemann, Udo
core
Sample size reassessment for a two-stage design controlling the false discovery rate. [PDF]
Zehetmayer S, Graf AC, Posch M.
europepmc +1 more source
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
A robust two-stage design identifying the optimal biological dose for phase I/II clinical trials. [PDF]
Zang Y, Lee JJ.
europepmc +1 more source

